Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
Béjot Y, Bailly H, Graber M, Garnier L, Laville A, Dubourget L, et al. Impact of the ageing population on the burden of stroke: the Dijon stroke registry. Neuroepidemiology. 2019;52(1–2):78–85.
Béjot Y. Forty years of descriptive epidemiology of stroke. Neuroepidemiology. 2022;56(3):157–62.
Cao Q, Tan C-C, Xu W, Hu H, Cao X-P, Dong Q, et al. The prevalence of dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2020;73(3):1157–66.
Leys D, Hénon H, Mackowiak-Cordoliani M-A, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752–9.
Kalaria RN, Ballard C. Stroke and cognition. Curr Atheroscler Rep. 2001;3(4):334–9.
Article CAS PubMed Google Scholar
Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M, et al. Post-stroke cognitive impairment and dementia. Circul Res. 2022;130(8):1252–71.
El Husseini N, Katzan IL, Rost NS, Blake ML, Byun E, Pendlebury ST, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a Scientific Statement from the American Heart Association/American Stroke Association. Stroke. 2023;54(6):e272–91.
Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, et al. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314(1):41–51.
Article CAS PubMed PubMed Central Google Scholar
Hurford R, Charidimou A, Fox Z, Cipolotti L, Werring DJ. Domain-specific trends in cognitive impairment after acute ischaemic stroke. J Neurol. 2013;260:237–41.
Group AI. Study design of ASPirin in reducing events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555–64.
Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology. 2020;95(3):e320–31.
Article CAS PubMed PubMed Central Google Scholar
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–18.
Article CAS PubMed PubMed Central Google Scholar
Cloud GC, Williamson JD, Thao LTP, Tran C, Eaton CB, Wolfe R, et al. Low-dose aspirin and the risk of stroke and Intracerebral Bleeding in healthy older people: secondary analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023;6(7):e2325803–e.
Article PubMed PubMed Central Google Scholar
Ernst ME, Broder JC, Wolfe R, Woods RL, Nelson MR, Ryan J, et al. Health characteristics and aspirin use in participants at the baseline of the aspirin in reducing events in the elderly–eXTension (ASPREE-XT) observational study. Contemp Clin Trials. 2023;130:107231.
McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, et al. Baseline characteristics of participants in the ASPREE (ASPirin in reducing events in the Elderly) study. Journals Gerontology: Ser A. 2017;72(11):1586–93.
Force WT. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular disorders. Stroke. 1989;20(10):1407–31.
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141(11):1356–64.
Article CAS PubMed Google Scholar
Pontón MO, Satz P, Herrera L, Ortiz F, Urrutia CP, Young R, et al. Normative data stratified by age and education for the neuropsychological screening battery for hispanics (NeSBHIS): initial report. J Int Neuropsychol Soc. 1996;2(2):96–104.
Alegret M, Boada-Rovira M, Vinyes-Junqué G, Valero S, Espinosa A, Hernández I, et al. Detection of visuoperceptual deficits in preclinical and mild Alzheimer’s disease. J Clin Exp Neuropsychol. 2009;31(7):860–7.
Article PubMed PubMed Central Google Scholar
Fish J. Alzheimer’s disease cooperative study ADL scale. Encyclopedia of clinical neuropsychology. New York, NY: Springer; 2011. pp. 111–2.
Meeting APA. Continuing Medical Education Syllabus and Scientific Proceedings in Summary Form: Annual Meeting of the American Psychiatric Association: American Psychiatric Association; 1994.
Zheng F, Yan L, Zhong B, Yang Z, Xie W. Progression of cognitive decline before and after incident stroke. Neurology. 2019;93(1):e20–8.
Lo JW, Crawford JD, Desmond DW, Bae H-J, Lim J-S, Godefroy O, et al. Long-term cognitive decline after stroke: an individual participant data meta-analysis. Stroke. 2022;53(4):1318–27.
Hua J, Dong J, Chen G-C, Shen Y. Trends in cognitive function before and after stroke in China. BMC Med. 2023;21(1):1–11.
Mahon S, Faulkner J, Barker-Collo S, Krishnamurthi R, Jones K, Feigin V. Slowed information processing speed at four years poststroke: evidence and predictors from a population-based follow-up study. J Stroke Cerebrovasc Dis. 2020;29(2):104513.
Gerritsen MJ, Berg IJ, Deelman BG, Visser-Keizer AC, Jong BM. -d. speed of information processing after unilateral stroke. J Clin Exp Neuropsychol. 2003;25(1):1–13.
Su C-Y, Wuang Y-P, Lin Y-H, Su J-H. The role of processing speed in post-stroke cognitive dysfunction. Arch Clin Neuropsychol. 2015;30(2):148–60.
Barker-Collo S, Feigin V, Parag V, Lawes C, Senior H. Auckland stroke outcomes study: part 2: cognition and functional outcomes 5 years poststroke. Neurology. 2010;75(18):1608–16.
Article CAS PubMed Google Scholar
Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev. 1996;103(3):403.
Article CAS PubMed Google Scholar
Rogers JM, Foord R, Stolwyk RJ, Wong D, Wilson PH. General and domain-specific effectiveness of cognitive remediation after stroke: systematic literature review and meta-analysis. Neuropsychol Rev. 2018;28:285–309.
Webb KL, Ryan J, Wolfe R, Woods RL, Shah RC, Murray AM, et al. Test-retest reliability and minimal detectable change of four cognitive tests in community-dwelling older adults. J Alzheimers Dis. 2022;87(4):1683–93.
Article PubMed PubMed Central Google Scholar
Quinn TJ, Elliott E, Langhorne P. Cognitive and mood assessment tools for use in stroke. Stroke. 2018;49(2):483–90.
留言 (0)